Biblio

2013
Danovi D, Folarin A, Gogolok S, Ender C, Elbatsh AMO, Engström PG, Stricker SH, Gagrica S, Georgian A, Yu D, et al. A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1. PLoS One. 2013;8(10):e77053.
Hansen A, Mjoseng HK, Zhang R, Kalloudis M, Koutsos V, de Sousa PA, Bradley M. High-Density Polymer Microarrays: Identifying Synthetic Polymers that Control Human Embryonic Stem Cell Growth. Adv Healthc Mater. 2013.
Yalçin B, Kremer LCm, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev. 2013;8:CD006301.
Seo J, Kim DHo, Lim JSub, Koh J-S, Yoo JYoung, Kong C-B, Song WSeok, Cho WHyeong, Jeon D-G, Lee S-Y, et al. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in the treatment of children and adolescents with Ewing sarcoma family of tumors. Korean J Pediatr. 2013;56(9):401-6.
Abramson JS. High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen. Haematologica. 2013;98(5):662-4.
Rancea M, Monsef I, von Tresckow B, Engert A, Skoetz N. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma. Cochrane Database Syst Rev. 2013;6:CD009411.
Boye K, Del Prever ABrach, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KSundby. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: Final results of the ISG/SSG II study. Pediatr Blood Cancer. 2013.
Schaich M, Parmentier S, Kramer M, Illmer T, Stölzel F, Röllig C, Thiede C, Hänel M, Schäfer-Eckart K, Aulitzky W, et al. High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 Trial. J Clin Oncol. 2013.
Huh YHoon, Cohen J, Sherley JL. Higher 5-hydroxymethylcytosine identifies immortal DNA strand chromosomes in asymmetrically self-renewing distributed stem cells. Proc Natl Acad Sci U S A. 2013.
Gómez-Almaguer D, Gómez-Peña A, Jaime-Pérez JCarlos, Gómez-Guijosa MÁngel, Cantú-Rodríguez O, Gutiérrez-Aguirre H, Martínez-Cabriales SAidé, García-Rodríguez F, Olguín-Ramírez LA, Salazar-Riojas R, et al. Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with clinically advanced disease. J Clin Apher. 2013.
Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan ISaramipoor, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, et al. Highly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem Cells. Stem Cells Transl Med. 2013.
Xin J, Yang H, Fan N, Zhao B, Ouyang Z, Liu Z, Zhao Y, Li X, Song J, Yang Y, et al. Highly Efficient Generation of GGTA1 Biallelic Knockout Inbred Mini-Pigs with TALENs. PLoS One. 2013;8(12):e84250.
Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng M-Q, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE, et al. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci U S A. 2013.
Bohr S, Patel SJ, Vasko R, Shen K, Huang G, Yarmush ML, Berthiaume F. Highly upregulated lhx2 in the foxn1(-/-) nude mouse phenotype reflects a dysregulated and expanded epidermal stem cell niche. PLoS One. 2013;8(5):e64223.
Cao K, Lailler N, Zhang Y, Kumar A, Uppal K, Liu Z, Lee EK, Wu H, Medrzycki M, Pan C, et al. High-resolution mapping of h1 linker histone variants in embryonic stem cells. PLoS Genet. 2013;9(4):e1003417.
Januszyk M, Gurtner GC. High-Throughput Single-Cell Analysis for Wound Healing Applications. Adv Wound Care (New Rochelle). 2013;2(9):457-469.
Hernigou P, Quiennec S, Guissou I. Hip hemiarthroplasty: from Venable and Bohlman to Moore and Thompson. Int Orthop. 2013.
Zickri MBaligh, Aziz DHussein Ab, Metwally HGabr. Histological experimental study on the effect of stem cell therapy on adriamycin induced chemobrain. Int J Stem Cells. 2013;6(2):104-12.
Sadek EMostafa, Afifi NMohamed, Elfattah LIbrahim Ab, Mohsen MAli Abd-El. Histological Study on Effect of Mesenchymal Stem Cell Therapy on Experimental Renal Injury Induced by Ischemia/Reperfusion in Male Albino Rat. Int J Stem Cells. 2013;6(1):55-66.
K Sankar D, P Bhanu S, Ramalingam K, Kiran S, Ramakrishna BA. Histomorphological and morphometrical changes of placental terminal villi of normotensive and preeclamptic mothers. Anat Cell Biol. 2013;46(4):285-90.
Malatesta M, Steinhauer C, Mohammad F, Pandey DP, Squartrito M, Helin K. Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation. Cancer Res. 2013.
Paino F, La Noce M, Tirino V, Naddeo P, Desiderio V, Pirozzi G, De Rosa A, Laino L, Altucci L, Papaccio G. Histone Deacetylase inhibition with Valproic Acid down-regulates Osteocalcin gene expression in Human Dental Pulp Stem Cells and Osteoblasts: Evidence for HDAC2 involvement. Stem Cells. 2013.
Lu J, Frerich JM, L Turtzo C, Li S, Chiang J, Yang C, Wang X, Zhang C, Wu C, Sun Z, et al. Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury. Proc Natl Acad Sci U S A. 2013.
Liu L, Souto J, Liao W, Jiang Y, Li Y, Nishinakamura R, Huang S, Rosengart T, Yang V, Schuster M, et al. Histone Demethylase LSD1 is Involved in SALL4 Mediated Transcriptional Repression in Hematopoietic Stem Cells. J Biol Chem. 2013.
Kerenyi MA, Shao Z, Hsu Y-J, Guo G, Luc S, O'Brien K, Fujiwara Y, Peng C, Nguyen M, Orkin SH. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation. Elife. 2013;2:e00633.

Pages